Innovations in Care
We provide programs and services that transform the lives of people affected by neuromuscular disease.
The North Star Ambulatory Assessment (NSAA) and its role in measuring impact in the Becker GRAND CANYON study
November 6th, 2024
1pm EST
Live, Virtual Webinar
Join Edgewise Therapeutics and Tina Duong MPT, PhD of Stanford University to learn about the North Star Ambulatory Assessment (NSAA) and its role in measuring disease progression and supporting therapy development. Learn about the NSAA activities, how it is scored, and how it is used as a clinical trial endpoint in studies like the Becker GRAND CANYON study. Information about the actively enrolling GRAND CANYON study will be shared.
